У нас вы можете посмотреть бесплатно CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP или скачать в максимальном доступном качестве, которое было загружено на ютуб. Для скачивания выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Please see Full Prescribing Information: https://bit.ly/3Ly3ru0 This video is intended for US healthcare professionals only. Tajuana Bradley, MS, FNP-BC discusses the management of patients taking CALQUENCE. Topics include the importance of treatment adherence, patient education, and additional strategies to help improve adherence. Select Safety Information CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Serious adverse events, including fatal events, have occurred with CALQUENCE, including serious and opportunistic infections, hemorrhage, cytopenias, second primary malignancies, cardiac arrhythmias, and hepatotoxicity, including drug-induced liver injury. The most common adverse reactions (≥30%) of any grade in patients with CLL were anemia, neutropenia, thrombocytopenia, headache, upper respiratory tract infection, and diarrhea.